Significant Opportunities Created by FDA in Generic Drug Development
Various changing factors in the US have resulted in the new availability of generic drug formulations.
On 21 June, new FDA commissioner Scott Gottlieb announced (in FDA Voice) said: "Too many patients are being priced out of the medicines they need. While FDA doesn’t have a direct role in drug pricing, we can take steps to help address this problem by facilitating increased competition in the market for prescription drugs through the approval of lower-cost, generic medicines."
Clinical trial consulting and pharmaceutical consulting professionals will benefit by becoming current on adaptive trial design.
Safety surveillance and pharmacovigilance consulting to generic drug manufacturers, as well as generic drug labelling consulting may soon become a service in demand.
Pharmaceutical Development Group (PDG) is a drug and medical device consultant that continuously engages in meetings and interactions with the US Food and Drug Administration...
Make an enquiry
Thank you for submitting the form. Your enquiry will be submitted to the company.